GRACE THERAPEUTICS INC. FIRST AMENDMENT TO THE STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
THIS FIRST AMENDMENT TO THE STOCKHOLDERS’ AGREEMENT (this “Amendment”) is made as of May 31, 2018 by and among Grace Therapeutics Inc., a Delaware corporation (the “Company”), and the undersigned Stockholders. Capitalized terms used but not defined herein have the meaning assigned to such terms in that certain Stockholders’ Agreement, by and between the Company and the signatories thereto, dated as of April 12, 2018 (the “Original Stockholders’ Agreement”).
GRACE THERAPEUTICS INC. STOCKHOLDERS’ AGREEMENTStockholders' Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
THIS STOCKHOLDERS’ AGREEMENT (this “Agreement”) is made and entered into as of this 12th day of April, 2018 (the “Effective Date”) by and among Grace Therapeutics Inc., a Delaware corporation (the “Company”), those certain stockholders of the Company listed on Schedule A and any subsequent stockholders who become party hereto as “Pharma Holders” pursuant to Section 7.2 and listed on Schedule A (the “Pharma Holders”), those certain stockholders of the Company listed on Schedule B and any subsequent stockholders who become party hereto as “Stockholders” pursuant to Section 7.1 or Section 7.2 and listed on Schedule B (together collectively with the Pharma Holders, the “Stockholders”). Capitalized terms not otherwise defined herein shall have the meanings set forth on Exhibit A attached hereto.
GRACE THERAPEUTICS INC. AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENTSConvertible Note Purchase Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENTS (this “Amendment”) is made as of [ , 2018] by and among Grace Therapeutics Inc., a Delaware corporation (the “Company”), and the undersigned Purchasers. Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Original Agreements (as defined below).
GRACE THERAPEUTICS INC. SECOND AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENTS AND AMENDMENT TO CONVERTIBLE PROMISSORY NOTESConvertible Note Purchase Agreements • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENTS AND AMENDMENT TO CONVERTIBLE PROMISSORY NOTES (this “Amendment”) is made as of [ , 2020], by and among Grace Therapeutics Inc., a Delaware corporation (the “Company”), and the undersigned purchasers (each, a “Purchaser” and collectively, the “Purchasers”). Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Agreements (as defined below).
GRACE THERAPEUTICS INC. CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
This Convertible Note Purchase Agreement (the “Agreement”) is made as of the day of [ , 2018] by and between Grace Therapeutics Inc., a Delaware corporation (the “Company”) having an office at 2 Tower Center Blvd., Suite 1101, East Brunswick, NJ 08816, and the purchaser identified on the signature page annexed hereto (the “Purchaser”) whose address is set forth on such signature page.
GRACE THERAPEUTICS LLC CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • New Jersey
This Convertible Note Purchase Agreement (the “Agreement”) is made as of the ___ day of [_________, 2017] by and between Grace Therapeutics LLC, a New Jersey limited liability company (the “Company”) and each of the purchasers listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
GRACE THERAPEUTICS INC. AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENT AND AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTESConvertible Note Purchase Agreement • July 1st, 2021 • Acasti Pharma Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENT AND AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTES (this “Amendment”) is made as of [ , 2020], by and among Grace Therapeutics Inc., a Delaware corporation (the “Company”), and each of the undersigned purchasers (each a “Purchaser” and together the “Purchasers”). Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Agreement (as defined below).
